Vera Therapeutics, Inc. · NASDAQ:VERA
T. Rowe Price Associates Inc reported a 5.70% stake in Vera Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
T. Rowe Price Associates Inc reported a 5.70% stake in Vera Therapeutics, Inc., 3,666,598 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 5.70%
- Shares
- 3,666,598
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 5.70% | 3,666,598 |
Source
Related
- Vera Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Vera Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · May 15, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Feb 17, 2026
- Form 4 · Fordyce Marshall · Sep 17, 2026
- Form 4 · Young Joseph R · Sep 14, 2026
- Form 4 · Fordyce Marshall · Sep 4, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026